ahlam1399
02-18-2016, 03:40 PM
UPDATE 1-Zafgen?s obesity drug succeeds in mid-stage trial
Feb 18 (Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Xw0H9sxX538:gD4sU2D79q8:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Xw0H9sxX538:gD4sU2D79q8:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Xw0H9sxX538:gD4sU2D79q8:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Xw0H9sxX538:gD4sU2D79q8:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Xw0H9sxX538:gD4sU2D79q8:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/Xw0H9sxX538
Feb 18 (Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Xw0H9sxX538:gD4sU2D79q8:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Xw0H9sxX538:gD4sU2D79q8:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Xw0H9sxX538:gD4sU2D79q8:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Xw0H9sxX538:gD4sU2D79q8:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Xw0H9sxX538:gD4sU2D79q8:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/Xw0H9sxX538